Latest Insider Transactions at Turning Point Therapeutics, Inc. (TPTX)
This section provides a real-time view of insider transactions for Turning Point Therapeutics, Inc. (TPTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Turning Point Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Turning Point Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 02
2021
|
Yi Larson EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,298
+45.68%
|
$772,092
$54.03 P/Share
|
|
Feb 02
2021
|
Annette North EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
9,016
-41.19%
|
$1,163,064
$129.25 P/Share
|
|
Feb 02
2021
|
Annette North EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
9,016
+50.0%
|
$153,272
$17.0 P/Share
|
|
Feb 01
2021
|
Yi Larson EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
15,702
-34.57%
|
$1,947,048
$124.33 P/Share
|
|
Feb 01
2021
|
Yi Larson EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
15,702
+46.04%
|
$847,908
$54.03 P/Share
|
|
Feb 01
2021
|
Annette North EVP & General Counsel |
SELL
Open market or private sale
|
Direct |
15,984
-67.63%
|
$1,966,032
$123.97 P/Share
|
|
Feb 01
2021
|
Annette North EVP & General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
15,984
+50.0%
|
$271,728
$17.0 P/Share
|
|
Jan 07
2021
|
Brian Lee Baker SVP of Finance and Admin. |
SELL
Open market or private sale
|
Direct |
31,238
-31.43%
|
$3,779,798
$121.97 P/Share
|
|
Jan 07
2021
|
Brian Lee Baker SVP of Finance and Admin. |
BUY
Exercise of conversion of derivative security
|
Direct |
28,438
+23.13%
|
$113,752
$4.49 P/Share
|
|
Jan 05
2021
|
Mohammad Hirmand EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,253
-81.52%
|
$150,360
$120.0 P/Share
|
|
Jan 05
2021
|
Mohammad Hirmand EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,253
+44.91%
|
$67,662
$54.73 P/Share
|
|
Jan 04
2021
|
Mohammad Hirmand EVP and Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
9,047
-50.04%
|
$1,094,687
$121.43 P/Share
|
|
Jan 04
2021
|
Mohammad Hirmand EVP and Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,747
+48.38%
|
$472,338
$54.73 P/Share
|
|
Jul 13
2020
|
Andrew John Partridge EVP & Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
21,500
+50.0%
|
-
|
|
Jun 09
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
9,500
-0.35%
|
$617,500
$65.7 P/Share
|
|
Jun 08
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-1.09%
|
$1,165,500
$63.26 P/Share
|
|
Jun 05
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.8%
|
$1,184,000
$64.44 P/Share
|
|
Jun 04
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.39%
|
$1,202,500
$65.56 P/Share
|
|
May 21
2020
|
Glaxosmithkline PLC Director |
BUY
Open market or private purchase
|
Indirect |
83,333
+3.57%
|
$4,999,980
$60.0 P/Share
|
|
May 21
2020
|
Athena Countouriotis President & CEO |
BUY
Open market or private purchase
|
Direct |
4,166
+13.42%
|
$249,960
$60.0 P/Share
|
|
May 21
2020
|
Simeon George Director |
BUY
Open market or private purchase
|
Indirect |
83,333
+3.57%
|
$4,999,980
$60.0 P/Share
|
|
May 21
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.57%
|
$413,000
$59.99 P/Share
|
|
May 20
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.38%
|
$420,000
$60.02 P/Share
|
|
May 19
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.28%
|
$399,000
$57.77 P/Share
|
|
May 08
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
11,500
-0.45%
|
$609,500
$53.92 P/Share
|
|
May 07
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.95%
|
$962,000
$52.99 P/Share
|
|
May 06
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-1.38%
|
$962,000
$52.84 P/Share
|
|
May 05
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.9%
|
$980,500
$53.92 P/Share
|
|
Apr 24
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.33%
|
$357,000
$51.3 P/Share
|
|
Apr 23
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.25%
|
$364,000
$52.56 P/Share
|
|
Apr 22
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.49%
|
$364,000
$52.03 P/Share
|
|
Apr 13
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
708
-0.03%
|
$34,692
$49.84 P/Share
|
|
Apr 09
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
11,500
-0.53%
|
$540,500
$47.79 P/Share
|
|
Apr 08
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.83%
|
$851,000
$46.51 P/Share
|
|
Apr 07
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.81%
|
$814,000
$44.76 P/Share
|
|
Apr 06
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.48%
|
$795,500
$43.43 P/Share
|
|
Mar 26
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
11,500
-0.36%
|
$529,000
$46.87 P/Share
|
|
Mar 25
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
17,792
-0.55%
|
$800,640
$45.88 P/Share
|
|
Mar 24
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.21%
|
$294,000
$42.2 P/Share
|
|
Mar 23
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.21%
|
$266,000
$38.2 P/Share
|
|
Mar 12
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.21%
|
$252,000
$36.47 P/Share
|
|
Mar 11
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.44%
|
$758,500
$41.74 P/Share
|
|
Mar 10
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.71%
|
$777,000
$42.45 P/Share
|
|
Feb 26
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.27%
|
$357,000
$51.84 P/Share
|
|
Feb 25
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.2%
|
$357,000
$52.0 P/Share
|
|
Feb 24
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.39%
|
$371,000
$53.91 P/Share
|
|
Feb 13
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
11,500
-0.36%
|
$701,500
$61.45 P/Share
|
|
Feb 12
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-0.76%
|
$1,221,000
$66.1 P/Share
|
|
Feb 11
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-1.12%
|
$1,165,500
$63.46 P/Share
|
|
Feb 10
2020
|
Jingrong Jean Cui Director |
SELL
Open market or private sale
|
Indirect |
18,500
-1.1%
|
$1,147,000
$62.95 P/Share
|